ADVFN US – Market Content Editor
-
North American Morning Briefing: Stock Futures Dip Ahead of Apple Event as Inflation Data Looms
Market Wraps Watch For: World Agricultural Supply & Demand Estimates Today’s Headlines/Must Reads – Banks Load Up on $1.2 Trillion in Risky ‘Hot’ Deposits – Five Things to Look for at Apple’s Tuesday iPhone Event – U.S. Takes Steps to Free $6 Billion in Iranian Funds in Prisoner-Swap Deal Opening Call: Traders appeared reluctant to…
-
US Futures Down, European Stocks Mixed
In the U.S. futures for the S&P 500 were down 0.2% and futures for the Dow Jones Industrial Average declined 0.1%. Changes in futures do not necessarily predict movements after the opening bell. In Europe, the Stoxx Europe 600 gained 0.1% in morning trading. HelloFresh rose 5.7% and Getinge Series B climbed 3.7%. On the…
-
Top Company News of the Day: UAW, Oracle, Apple, Shar Redstone
UAW Bends on Wage Demands as Talks Progress in Detroit The union has proposed a mid-30% wage increase, down from an initial demand of at least 40%. Oracle stock sinks as revenue outlook falls below Wall Street consensus Oracle Corp. shares fell further in the extended session Monday after the software company’s forecast disappointed. Five…
-
U.S. Stocks Most Mostly Higher, Nasdaq Jumps Following Tesla Upgrade
Following the notable pullback seen last week, stocks moved mostly higher during trading on Monday. The major averages all moved to the upside on the day, adding to the modest gains posted last Friday. The major averages all closed in positive territory, with the tech-heavy Nasdaq posting a standout gain. The Nasdaq jumped 156.37 points…
-
Crypto This Monday: Coinbase Faces Challenges in India, Restructuring at Celsius, and More
Bitcoin transaction fee record: User pays $500,000 due to error One individual made a costly mistake, paying nearly $500,000 (20 bitcoins) in fees to transfer just $200 worth of bitcoin (COIN:BTCUSD). This transaction, which took place on September 10th, sets the record for the highest transaction fee in Bitcoin. The transaction caught the attention of Casa’s CTO,…
-
Tesla Upgrade May Help U.S. Stocks Recover From Last Week’s Pullback
US Market The major U.S. index futures are currently pointing to a higher open on Monday, with stocks likely to regain ground following the notably pullback seen last week. The tech-heavy Nasdaq may receive a boost from a surge by shares of Tesla (TSLA), with the electric car maker jumping by 6.4 percent in pre-market…
-
Keep An Eye Out: Pre-Market Movers And Recommendations
Every morning, find a selection of analysts’ recommendations. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. US Options Trader Live Realtime Streaming: US Options (OPRA), NYSE, NASDAQ, AMEX prices + Dow Jones and S&P indices – and our innovative Options…
-
Monday’s Wall Street Highlights: Alibaba, Tesla, Kenvue, Boeing, and more
US index futures are higher in pre-market trading on Monday, even with continued uncertainty about the global economy. The week will be marked by the monetary decision of the European Central Bank (ECB) and American inflation data, influencing Federal Reserve’s decisions. At 6:53 AM, Dow Jones futures (DOWI:DJI) rose 71 points, or 0.20%. S&P 500 futures rose…
-
Nvidia’s Dominance in AI Chips Stifles Investment in Startups
Nvidia’s (NASDAQ:NVDA) supremacy in building computer chips for artificial intelligence has cooled venture funding for potential rivals, according to investors, with the number of deals in the U.S. this quarter dropping 80% compared to the previous year. The Santa Clara, California-based company dominates the market for chips that power large-scale language data processing. AI generative…
-
AstraZeneca Says Lung Cancer Drug Showed Durable Tumor Response in Mid-Stage Trial
AstraZeneca (NASDAQ:AZN) (LSE:AZN) said on Monday that its drug Enhertu showed a strong and durable tumor response as a potential treatment for patients with certain types of non-small cell lung cancer in a phase 1 trial. Enhertu, co-developed with Daiichi Sankyo, showed objective response rates of 49% at the 5.4 mg/kg dose and 56% at…